Literature DB >> 27782332

The complement factor H-related proteins.

Nicholas Medjeral-Thomas1, Matthew C Pickering2.   

Abstract

The role of the complement factor H-related (FHR) proteins in homeostasis, pathogen defense, and autoimmune disease has recently attracted considerable interest. We highlight the exciting research that has contributed to our understanding of the FHR protein family. Unlike factor H, a potent negative regulator of complement C3 activation, the FHR proteins appear to promote C3 activation. These data have important implications for understanding complement-mediated diseases because, depending on the context, the balance between the actions of factor H and the FHR proteins determines the degree of complement activation.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  complementinflammation; infection; kidney

Mesh:

Substances:

Year:  2016        PMID: 27782332     DOI: 10.1111/imr.12477

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  31 in total

Review 1.  CFHR Gene Variations Provide Insights in the Pathogenesis of the Kidney Diseases Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy.

Authors:  Peter F Zipfel; Thorsten Wiech; Emma D Stea; Christine Skerka
Journal:  J Am Soc Nephrol       Date:  2020-01-24       Impact factor: 10.121

2.  Factor H: a novel modulator in sickle cell disease.

Authors:  Wassim El Nemer; Bérengère Koehl
Journal:  Haematologica       Date:  2019-05       Impact factor: 9.941

Review 3.  Complement component C3 - The "Swiss Army Knife" of innate immunity and host defense.

Authors:  Daniel Ricklin; Edimara S Reis; Dimitrios C Mastellos; Piet Gros; John D Lambris
Journal:  Immunol Rev       Date:  2016-11       Impact factor: 12.988

4.  Altered Peripheral Blood Leucocyte Phenotype and Responses in Healthy Individuals with Homozygous Deletion of FHR1 and FHR3 Genes.

Authors:  Angika Bhasym; Bahadur Singh Gurjar; Savit Prabhu; Mamta Puraswani; Priyanka Khandelwal; Himanshi Saini; Savita Saini; Priyadarshini Chatterjee; Vineeta Bal; Anna George; Poonam Coshic; Gopal Patidar; Pankaj Hari; Aditi Sinha; Arvind Bagga; Satyajit Rath; Prasenjit Guchhait
Journal:  J Clin Immunol       Date:  2019-04-03       Impact factor: 8.317

Review 5.  Kidney Diseases Associated With Alternative Complement Pathway Dysregulation and Potential Treatment Options.

Authors:  Prateek Sanghera; Mythili Ghanta; Fatih Ozay; Venkatesh K Ariyamuthu; Bekir Tanriover
Journal:  Am J Med Sci       Date:  2017-03-16       Impact factor: 2.378

Review 6.  The properdin pathway: an "alternative activation pathway" or a "critical amplification loop" for C3 and C5 activation?

Authors:  Richard A Harrison
Journal:  Semin Immunopathol       Date:  2017-11-22       Impact factor: 9.623

Review 7.  C3 glomerulopathy - understanding a rare complement-driven renal disease.

Authors:  Richard J H Smith; Gerald B Appel; Anna M Blom; H Terence Cook; Vivette D D'Agati; Fadi Fakhouri; Véronique Fremeaux-Bacchi; Mihály Józsi; David Kavanagh; John D Lambris; Marina Noris; Matthew C Pickering; Giuseppe Remuzzi; Santiago Rodriguez de Córdoba; Sanjeev Sethi; Johan Van der Vlag; Peter F Zipfel; Carla M Nester
Journal:  Nat Rev Nephrol       Date:  2019-03       Impact factor: 28.314

Review 8.  Dominant C3 glomerulopathy: new roles for an old actor in renal pathology.

Authors:  Nicola Pirozzi; Antonella Stoppacciaro; Paolo Menè
Journal:  J Nephrol       Date:  2017-11-18       Impact factor: 3.902

Review 9.  The role of the alternative pathway of complement activation in glomerular diseases.

Authors:  Emilia Łukawska; Magdalena Polcyn-Adamczak; Zofia I Niemir
Journal:  Clin Exp Med       Date:  2018-02-15       Impact factor: 3.984

10.  Molecular bases for the association of FHR-1 with atypical hemolytic uremic syndrome and other diseases.

Authors:  Héctor Martin Merinero; Marta Subías; Amaia Pereda; Elena Gómez-Rubio; Lucia Juana Lopez; Constantino Fernandez; Elena Goicoechea de Jorge; Sonsoles Martin-Santamaria; Francisco Javier Cañada; Santiago Rodríguez de Córdoba
Journal:  Blood       Date:  2021-06-24       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.